Iovance Biotherapeutics to Present at Upcoming Conferences and Events

Posted: May 27, 2024 at 2:47 am

SAN CARLOS, Calif., May 24, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that senior leadership plans to present at the following conferences and events:

Original post:
Iovance Biotherapeutics to Present at Upcoming Conferences and Events

Related Posts